SCHEMBL7955669

SCHEMBL7955669

NC[C@H](N)COCc1ccccc1F

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.52
TAAR1 Q96RJ0 1/20 0.46
MAOB P27338 5/20 0.45
ALDH1A1 P00352 2/20 0.42
TACR1 P25103 4/20 0.39
PARP15 Q460N3 1/20 0.39
PARP14 Q460N5 1/20 0.39
PARP10 Q53GL7 1/20 0.39
SLC1A5 Q15758 1/20 0.39
PTPN1 P18031 1/20 0.39
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
SLC6A2 P23975 1/20 0.38
SLC6A4 P31645 1/20 0.38
SLC6A3 Q01959 1/20 0.38
KCNH2 Q12809 1/20 0.38
KDM4E B2RXH2 1/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MCL1 Q07820 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7955676 1.00 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1TACR1
SCHEMBL7964814 0.79 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1TACR1
SCHEMBL7964819 0.79 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1TACR1
SCHEMBL7965699 0.79 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1TACR1
SCHEMBL7965694 0.79 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1TACR1
SCHEMBL7956663 0.77 IDO1 (0.54) IDO1TAAR1ALDH1A1TACR1KDM4E
SCHEMBL2714973 0.77 IDO1 (0.67) IDO1TAAR1MAOBALDH1A1PARP15
SCHEMBL31065556 0.77 IDO1 (0.67) IDO1TAAR1MAOBALDH1A1PARP15
SCHEMBL13676865 0.77 IDO1 (0.52) IDO1TAAR1MAOBALDH1A1PARP15
SCHEMBL7965700 0.76 TACR1 (0.59) IDO1TACR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6274715-B1 SEMISYNTHETIC MACROLIDES, USEFUL IN BACTERIAL INFECTIONS TREATMENT AND PREVENTION, HAS LESS POTENTIAL FOR DEVELOPING RESISTANCE, IMPROVED OR MODIFIED PROFILES OF DESIRED GRAM-NEGATIVE ACTIVITY ABBOTT LABORATORIES 2001-08-14 US disclosed
EP-0961776-A1 TRICYCLIC ERYTHROMYCIN DERIVATIVES Abbott Laboratories (US) 1999-12-08 EP disclosed
WO-1998030574-A1 TRICYCLIC ERYTHROMYCIN DERIVATIVES ABBOTT LABORATORIES (US) 1998-07-16 WO disclosed